The Regulatory Landscape for Clinical Metagenomic Testing
This Viewpoint discusses regulatory shifts and their effects on access to innovative diagnostic tests and provides ways to address regulatory barriers for clinical metagenomic testing.
Authors
- Jutte J.C. de Vries (ORCID: https://orcid.org/0000-0003-2530-6260)
- Michael R. Wilson (ORCID: https://orcid.org/0000-0002-8705-5084)
- Charles Y. Chiu (ORCID: https://orcid.org/0000-0003-2915-2094)
- F. Xavier López‐Labrador (ORCID: https://orcid.org/0000-0002-9403-8258)
Institutions
- Universitat de València (ES)
- University of California, San Francisco (US)
- Leiden University Medical Center (NL)
- Generalitat Valenciana (ES)
- Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (ES)
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES)
Publication Details
- Journal
- JAMA Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1001/jamaneurol.2025.0461
- Citations
- 4
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 3.75